1-8 of 8
Neil D. Gross
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO-074: The evolution of the tumor immune microenvironment in immunosuppressed patients with cutaneous squamous cell carcinoma

Mica D. E. Glaun, Frederico O. Gleber-Netto, Priyadharsini Nagarajan, Tongxin Xie, Shamima Akhter, Yu Han Chen, Erez Baruch N. Baruch, Michael K. Wong, Emily Y. Chu, Kenneth Y. Tsai, Elsa R. Flores, Deborah A. Silverman, Ryan P. Goepfert, Murat Cobanoglu, Jared Burks, Padmanee Sharma, James P. Allison, Jeffrey N. Myers, Neil D. Gross, Moran Amit
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (18_Supplement): PO-074.
https://doi.org/10.1158/1557-3265.AACRAHNS23-PO-074
Published: 15 September 2023
View article titled, Abstract PO-074: The evolution of the tumor immune microenvironment in immunosuppressed patients with cutaneous squamous cell carcinoma
Journal Articles

Functional Genetic Variants in TGFβ1 and TGFβR1 in miRNA-Binding Sites Predict Outcomes in Patients with HPV-positive Oropharyngeal Squamous Cell Carcinoma

Zihao Niu, Peng Sun, Hongliang Liu, Peng Wei, Jia Wu, Zhigang Huang, Neil D. Gross, Sanjay Shete, Qingyi Wei, Mark E. Zafereo, George A. Calin, Guojun Li
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (16): 3081–3091.
https://doi.org/10.1158/1078-0432.CCR-23-1161
Published: 15 August 2023
View article titled, Functional Genetic Variants in <em>TGFβ1</em> and <em>TGFβR1</em> in miRNA-Binding Sites Predict Outcomes in Patients with HPV-positive Oropharyngeal Squamous Cell Carcinoma
Open the PDF for Functional Genetic Variants in <em>TGFβ1</em> and <em>TGFβR1</em> in miRNA-Binding Sites Predict Outcomes in Patients with HPV-positive Oropharyngeal Squamous Cell Carcinoma in another window
Journal Articles

Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, M. Laura Rubin, Ying Yuan, Diana Bell, Adel K. El-Naggar, Jason M. Johnson, William H. Morrison, David I. Rosenthal, Bonnie S. Glisson, Faye M. Johnson, Charles Lu, Frank E. Mott, Bita Esmaeli, Eduardo M. Diaz, Jr, Paul W. Gidley, Ryan P. Goepfert, Carol M. Lewis, Randal S. Weber, Jennifer A. Wargo, Sreyashi Basu, Fei Duan, Shalini S. Yadav, Padmanee Sharma, James P. Allison, Jeffrey N. Myers, Neil D. Gross
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (8): 1735.
https://doi.org/10.1158/1078-0432.CCR-22-0468
Published: 14 April 2022
View article titled, Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
Open the PDF for Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck in another window
Includes: Supplementary data
Journal Articles

Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, M. Laura Rubin, Ying Yuan, Diana Bell, Adel K. El-Naggar, Jason M. Johnson, William H. Morrison, David I. Rosenthal, Bonnie S. Glisson, Faye M. Johnson, Charles Lu, Frank E. Mott, Bita Esmaeli, Eduardo M. Diaz, Jr, Paul W. Gidley, Ryan P. Goepfert, Carol M. Lewis, Randal S. Weber, Jennifer A. Wargo, Sreyashi Basu, Fei Duan, Shalini S. Yadav, Padmanee Sharma, James P. Allison, Jeffrey N. Myers, Neil D. Gross
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (16): 4557–4565.
https://doi.org/10.1158/1078-0432.CCR-21-0585
Published: 15 August 2021
View article titled, Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
Open the PDF for Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck in another window
Includes: Supplementary data
Journal Articles

Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+ Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results

Renata Ferrarotto, Diana Bell, Maria L. Rubin, Katherine A. Hutcheson, Jason M. Johnson, Ryan P. Goepfert, Jack Phan, Yasir Y. Elamin, Danice K. Torman, Carla L. Warneke, Amy C. Hessel, Adam S. Garden, Jeffrey N. Myers, Faye M. Johnson, J. Jack Lee, Andrew G. Sikora, Maura L. Gillison, Bonnie S. Glisson, Neil D. Gross
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13): 3211–3219.
https://doi.org/10.1158/1078-0432.CCR-19-3977
Published: 01 July 2020
View article titled, Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8<sup>+</sup> Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results
Open the PDF for Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8<sup>+</sup> Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results in another window
Includes: Supplementary data
Journal Articles

Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer

Neil D. Gross, Julie E. Bauman, William E. Gooding, William Denq, Sufi M. Thomas, Lin Wang, Simion Chiosea, Brian L. Hood, Melanie S. Flint, Mai Sun, Thomas P. Conrads, Robert L. Ferris, Jonas T. Johnson, Seungwon Kim, Athanassios Argiris, Lori Wirth, Marina N. Nikiforova, Jill M. Siegfried, Jennifer R. Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (12): 3289–3298.
https://doi.org/10.1158/1078-0432.CCR-13-3360
Published: 12 June 2014
View article titled, Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer
Open the PDF for Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Inhibition of Jun NH2-Terminal Kinases Suppresses the Growth of Experimental Head and Neck Squamous Cell Carcinoma

Neil D. Gross, Jay O. Boyle, Baoheng Du, Vikram D. Kekatpure, Agnieszka Lantowski, Howard T. Thaler, Babette B. Weksler, Kotha Subbaramaiah, Andrew J. Dannenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5910–5917.
https://doi.org/10.1158/1078-0432.CCR-07-0352
Published: 01 October 2007
View article titled, Inhibition of Jun NH<sub>2</sub>-Terminal Kinases Suppresses the Growth of Experimental Head and Neck Squamous Cell Carcinoma
Open the PDF for Inhibition of Jun NH<sub>2</sub>-Terminal Kinases Suppresses the Growth of Experimental Head and Neck Squamous Cell Carcinoma in another window
Journal Articles

Levels of Prostaglandin E Metabolite, the Major Urinary Metabolite of Prostaglandin E2, Are Increased in Smokers

Neil D. Gross, Jay O. Boyle, Jason D. Morrow, Myles K. Williams, Chaya S. Moskowitz, Kotha Subbaramaiah, Andrew J. Dannenberg, Anna J. Duffield-Lillico
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (16): 6087–6093.
https://doi.org/10.1158/1078-0432.CCR-05-0733
Published: 22 August 2005
View article titled, Levels of Prostaglandin E Metabolite, the Major Urinary Metabolite of Prostaglandin E<sub>2</sub>, Are Increased in Smokers
Open the PDF for Levels of Prostaglandin E Metabolite, the Major Urinary Metabolite of Prostaglandin E<sub>2</sub>, Are Increased in Smokers in another window